Originally published October 24th 2022 [Old Format]
Trade Rationale and Plan
• Per the plan in Monday’s report, I have bought a hedge against potential P&L damage to my core Short Nasdaq 100 (c.10% position) from an aggressive risk rally through the balance of the year (called / hoped for by many) using the IBB (iShares Biotech ETF).
• Biotech is one of th…